Please login to the form below

Not currently logged in
Email:
Password:

HTA guidance from NICE, the SMC and the AWMSG

Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG).

Provided by Guidelines, it also features: NICE clinical guidelines, NICE quality standards, NICE evidence updates, NICE evidence summaries, independent professional body guidelines and (Scottish Intercollegiate Guidelines Network (SIGN) guidance.

Cerebral palsy in under 25s: assessment and management

January 2017: NICE Clinical Guideline

Combined hormonal contraception—update (Faculty of Sexual & Reproductive Healthcare)

January 2017: Independent professional body guideline

Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK (National Osteoporosis Guideline Group)

January 2017: Independent professional body guideline

Infliximab for extrapulmonary sarcoidosis

January 2017: NICE Evidence summary: unlicensed/off-label medicines

Falls: prevention

January 2017: NICE Quality Standard

Cutaneous melanoma (update)

January 2017: SIGN guidance

Antimicrobial stewardship—changing risk-related behaviours in the general population

January 2017: NICE Public Health Guidance

Drug misuse prevention

February 2017: NICE Public Health Guidance

Hidradenitis suppurativa—update (British Association of Dermatologists)

February 2017: Independent professional body guideline

Management of gout (British Society for Rheumatology)

February 2017: Independent professional body guideline

Visit the Guidelines website

NICE U-turn on Novartis' Afinitor for kidney cancer

NICE U-turn on Novartis' Afinitor for kidney cancer 16 Jan 2017
Set to back treatment's routine NHS use following offer of discount and new data

NICE recognises Smartinhaler as best practice for asthma care

NICE recognises Smartinhaler as best practice for asthma care 11 Jan 2017
Digital monitoring device proven to increase adherence and reduce hospital visits

NICE green lights Keytruda for second-line lung cancer

NICE green lights Keytruda for second-line lung cancer 5 Dec 2016
Merck & Co's oncology treatment backed in draft guidance for NSCLC

NICE changes stance on GSK's asthma drug Nucala

NICE changes stance on GSK's asthma drug Nucala 1 Dec 2016
A newly-agreed price cut and additional cost-effectiveness data prompt U-turn

NICE U-turn sees Celgene's Imnovid backed for multiple myeloma

NICE U-turn sees Celgene's Imnovid backed for multiple myeloma 30 Nov 2016
New data and a discount swayed the cost-effectiveness body

More news from PMLiVE on NICE, the SMC and the AWMSG

MGP’s Guidelines brand is trusted by over 58,000 healthcare professionals for concise clinical summaries of major primary and shared care guidelines in the UK. Through Guidelines, Guidelines for Nurses and Guidelines in Practice, MGP connect pharmaceutical and medical device companies to an engaged audience of GPs, GP commissioners and payers, nurses and allied healthcare professionals.

To discuss how we can support your guidance or implementation needs please contact marketing@mgp.co.uk

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Reynolds-MacKenzie

Reynolds-MacKenzie is the multi award-winning specialist public relations practice within OPEN Health; the first ever agency in the health communications...

Infographics